135 related articles for article (PubMed ID: 12644367)
1. Non-degradable microparticles containing a hydrophilic and/or a lipophilic drug: preparation, characterization and drug release modeling.
Hombreiro-Pérez M; Siepmann J; Zinutti C; Lamprecht A; Ubrich N; Hoffman M; Bodmeier R; Maincent P
J Control Release; 2003 Mar; 88(3):413-28. PubMed ID: 12644367
[TBL] [Abstract][Full Text] [Related]
2. The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug.
Hombreiro Pérez M; Zinutti C; Lamprecht A; Ubrich N; Astier A; Hoffman M; Bodmeier R; Maincent P
J Control Release; 2000 Apr; 65(3):429-38. PubMed ID: 10699300
[TBL] [Abstract][Full Text] [Related]
3. Nifedipine molecular dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blends for controlled drug delivery: effect of matrix composition.
Huang J; Wigent RJ; Schwartz JB
Drug Dev Ind Pharm; 2006; 32(10):1185-97. PubMed ID: 17090441
[TBL] [Abstract][Full Text] [Related]
4. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
Alhnan MA; Basit AW
Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
[TBL] [Abstract][Full Text] [Related]
5. Effect of the size of biodegradable microparticles on drug release: experiment and theory.
Siepmann J; Faisant N; Akiki J; Richard J; Benoit JP
J Control Release; 2004 Apr; 96(1):123-34. PubMed ID: 15063035
[TBL] [Abstract][Full Text] [Related]
6. A new mathematical model quantifying drug release from bioerodible microparticles using Monte Carlo simulations.
Siepmann J; Faisant N; Benoit JP
Pharm Res; 2002 Dec; 19(12):1885-93. PubMed ID: 12523670
[TBL] [Abstract][Full Text] [Related]
7. Process and formulation variables of pregabalin microspheres prepared by w/o/o double emulsion solvent diffusion method and their clinical application by animal modeling studies.
Aydogan E; Comoglu T; Pehlivanoglu B; Dogan M; Comoglu S; Dogan A; Basci N
Drug Dev Ind Pharm; 2015; 41(8):1311-20. PubMed ID: 25119000
[TBL] [Abstract][Full Text] [Related]
8. Drug release mechanisms of compressed lipid implants.
Kreye F; Siepmann F; Siepmann J
Int J Pharm; 2011 Feb; 404(1-2):27-35. PubMed ID: 21055453
[TBL] [Abstract][Full Text] [Related]
9. Effect of Particle Size on Drug Loading and Release Kinetics of Gefitinib-Loaded PLGA Microspheres.
Chen W; Palazzo A; Hennink WE; Kok RJ
Mol Pharm; 2017 Feb; 14(2):459-467. PubMed ID: 27973854
[TBL] [Abstract][Full Text] [Related]
10. Mathematical modeling of drug release from bioerodible microparticles: effect of gamma-irradiation.
Faisant N; Siepmann J; Richard J; Benoit JP
Eur J Pharm Biopharm; 2003 Sep; 56(2):271-9. PubMed ID: 12957642
[TBL] [Abstract][Full Text] [Related]
11. Drug release from extruded solid lipid matrices: theoretical predictions and independent experiments.
Güres S; Siepmann F; Siepmann J; Kleinebudde P
Eur J Pharm Biopharm; 2012 Jan; 80(1):122-9. PubMed ID: 22008146
[TBL] [Abstract][Full Text] [Related]
12. Nifedipine solid dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blend for controlled drug delivery. Effect of drug loading on release kinetics.
Huang J; Wigent RJ; Bentzley CM; Schwartz JB
Int J Pharm; 2006 Aug; 319(1-2):44-54. PubMed ID: 16678366
[TBL] [Abstract][Full Text] [Related]
13. Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend.
Huang J; Wigent RJ; Schwartz JB
J Pharm Sci; 2008 Jan; 97(1):251-62. PubMed ID: 17724668
[TBL] [Abstract][Full Text] [Related]
14. Impact of dispersion time interval and particle size on release profiles of propranolol HCl and carbamazepines from microparticle blends system.
Muhaimin M; Chaerunisaa AY; Bodmeier R
Sci Rep; 2022 Jun; 12(1):10360. PubMed ID: 35726009
[TBL] [Abstract][Full Text] [Related]
15. Comparison of microencapsulation by emulsion-solvent extraction/evaporation technique using derivatives cellulose and acrylate-methacrylate copolymer as carriers.
Jelvehgari M; Montazam SH
Jundishapur J Nat Pharm Prod; 2012; 7(4):144-52. PubMed ID: 24624173
[TBL] [Abstract][Full Text] [Related]
16. Spray-drying enteric polymers from aqueous solutions: a novel, economic, and environmentally friendly approach to produce pH-responsive microparticles.
Alhnan MA; Kidia E; Basit AW
Eur J Pharm Biopharm; 2011 Oct; 79(2):432-9. PubMed ID: 21439376
[TBL] [Abstract][Full Text] [Related]
17. Poly (epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics.
Karataş A; Sonakin O; Kiliçarslan M; Baykara T
J Microencapsul; 2009 Feb; 26(1):63-74. PubMed ID: 18608798
[TBL] [Abstract][Full Text] [Related]
18. Poly(epsilon-caprolactone) and Eudragit microparticles containing fludrocortisone acetate.
Gibaud S; Jabir Al Awwadi N; Ducki C; Astier A
Int J Pharm; 2004 Jan; 269(2):491-508. PubMed ID: 14706260
[TBL] [Abstract][Full Text] [Related]
19. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
20. Drug loading into porous calcium carbonate microparticles by solvent evaporation.
Preisig D; Haid D; Varum FJ; Bravo R; Alles R; Huwyler J; Puchkov M
Eur J Pharm Biopharm; 2014 Aug; 87(3):548-58. PubMed ID: 24568926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
